ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag scientific misconduct microbiology immunology

Week in Review, July 8–12
Jef Akst | Jul 12, 2013 | 4 min read
Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism
What Can We Learn From The Investigation Of Misconduct?
The Scientist Staff | Jun 25, 1989 | 10+ min read
[Editor's note: Discussions of research misconduct are becoming more and more prevalent, in the halls of academic and research institutions as well as on the front pages of newspapers. But few in the scientific community have experienced the issue as personally as the six authors of the now infamous Cell paper, among them MIT's David Baltimore and Tufts' Thereza ImanishiKari. Since May 1986, when Margot O'Toole, a postdoc working in Imanishi-Kari's lab at MIT, first raised doubts about some of t
The Biggest Science Scandals of 2017
Jef Akst | Dec 15, 2017 | 5 min read
This year’s controversial news included unethical behavior among politicians, a murder, and multiple accusations of gender discrimination and sexual harassment, in addition to the usual spate of research misconduct.
Solving Irreproducible Science
Connor Bamford | Sep 26, 2012 | 3 min read
Will the recently launched Reproducibility Initiative succeed in cleaning up research and reducing retractions?
Scientific Analysis: No AIDS-Polio Vaccine Link
Myrna Watanabe | Oct 1, 2000 | 2 min read
At a Sept. 11 meeting of the Royal Society of London, convened to discuss the origin of HIV/AIDS, researchers aired scientific data showing that the hypothesis that HIV/AIDS originated from an experimental oral polio vaccine had no scientific merit. The hypothesis was popularized by journalist Edward Hooper in his 1999 book, The River,1 and supported by the late evolutionary biologist William Hamilton. It states that a type of oral poliovirus vaccine (OPV) called CHAT, produced by Hilary Koprows
Multiple Investigations
Billy Goodman | Aug 18, 1996 | 10+ min read
Changes In System REHIRED: Following her exoneration, Thereza Imanishi-Kari was named an associate professor at Tufts University. Participants, observers say the case highlighted a need to overhaul the mechanism for dealing with charges of scientific misconduct. The conclusion of the decade-long scientific misconduct case against Thereza Imanishi-Kari-she was exonerated in a June 21 decision of an appeals panel of the Department of Health and Human Services (HHS)-would appear to be a clear-cu
June 2019 Contributors
Contributors
The Scientist | Jun 1, 2019 | 3 min read
Meet some of the people featured in the June 2019 issue of The Scientist.
Suited to a T
Kelly Rae Chi | May 1, 2013 | 8 min read
Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
No Mo’ Slow Flow
Jeffrey M. Perkel | Jan 1, 2012 | 7 min read
Tools and tricks for high-throughput flow cytometry

Run a Search

ADVERTISEMENT